Web Site Helps Alleviate Stress Associated with Caring for Children with Diabetes During the Holiday

AbbottHolidays often induce stress, but caring for children with diabetes this time of year can mean an additional layer of pressure. Parents and caregivers can visit a webiste to participate in live Web chats with diabetes specialists for expert advice on how to best manage a child's diabetes during the holidays, find social support and receive a free download of the 'Diabetes Fit Food' booklet for tips on healthy eating.

The Web site and tools are in response to a recent survey conducted by Children with Diabetes and sponsored by Abbott Diabetes Care which found that 93 percent of parents who had a child with diabetes reported it is challenging to stick to regular diabetes' routines during the holidays, defined as the time between Thanksgiving and New Year's. These parents also said their children experience more periods of uncontrolled blood glucose during this time, which can have serious health consequences. Because of these two factors - disrupted routines and fluctuating glucose levels - many parents said they feel the need to measure their child's glucose level during the holiday season "more often than usual."

Almost 60 percent of parents surveyed said stress levels increase when it comes to caring for children with diabetes during the holiday season, with the major challenge being the disruption of normal daily routines during this time. A majority of respondents said support from family, friends and healthcare professionals, as well as interactive educational tools, such as Web chats and online forums, would help decrease their anxiety and enable them to better manage their child's diabetes.

Online tools to help with caring for children with diabetes during the holidays will be available from Nov. 8, 2007 through Jan. 3, 2008.

For further information, please visit:
http://www.abbottdiabetescare.com

Additional resources:
http://www.childrenwithdiabetes.com
http://www.diabetes.org/home.jsp
http://www.abbott.com
http://www.dlife.com
http://www.diabetescontrolforlife.com
http://www.jdrf.org

About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

Most Popular Now

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

The fourth COVID-19 vaccine reduces the risk of de…

A new study by Tel Aviv University and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that the fourth COVID-19 vaccin...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

Research shows investigational drug fosters nerve …

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of da...

NIH launches clinical trial of mRNA Nipah virus va…

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an inv...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...